A follow-up study of young adults who were diagnosed years earlier with childhood-onset bipolar disorder suggests that their cognitive flexibility—in many cases already impaired at the time of…
Read More
Cariprazine, a medicine approved by the FDA in 2015 for the treatment of manic episodes in bipolar I disorder, was effective in reducing depressive symptoms in bipolar I disorder patients in a phase…
Read More
A multi-decade study focusing on children of parents diagnosed with bipolar disorder quantifies the risk—24.5%—that they themselves will develop bipolar illness, and suggests a “progressive sequence…
Read More